Recent Funding
Investors
F-Prime Capital

F-Prime Capital portfolio

F-Prime Capital has 61 portfolio companies on record at Recent Funding, with 14 investments in the last 12 months.

Website: fprimecapital.com.

Type: Venture capital.

Portfolio on Recent Funding: 61.

Deals, last 12 months: 14.

Rounds led: 23 of 74.

Capital in their rounds: $4.08B.

Latest deal: T-Therapeutics · Nov 5, 2026.

About this page

It is a venture capital firm based in Cambridge, US, founded in 2002. It led 23 of the 74 rounds it joined. Its most recent investment on record is T-Therapeutics's $133M Series B+ round in November 2026, alongside Digitalis Ventures, Cambridge Innovation Capital, Johnson & Johnson Innovation and 6 others. By category, its portfolio leans toward Health and bio (34) and Fintech (11). It has co-invested with Eight Roads Ventures, Y Combinator and Commerce Ventures, most often Eight Roads Ventures (14 rounds).

About F-Prime Capital

Firm type: Venture capital.

Headquarters: Cambridge, US.

Founded: 2002.

Stages: Pre-Seed, Seed, Series A, Series B, Series C.

Sectors: AI & Machine Learning, Biotech, Crypto & Web3, Deep Tech, Digital Health, Enterprise Software, Fintech, Healthtech, InsurTech, Medical Devices, Mental Health, SaaS, Sector Agnostic.

Check size: $3M to $10M.

Leads rounds: Yes.

Portfolio companies: 396.

Exits: 63.

Rounds led: 35.

What F-Prime Capital invests in

Health and bio · 34 · 56%
Fintech · 11 · 18%
Stablecoins · 5 · 8%
Sales and marketing · 5 · 8%
Logistics and mobility · 4 · 7%
Manufacturing and industrial · 4 · 7%
Crypto payments · 4 · 7%
Consumer and social · 4 · 7%

F-Prime Capital recent investments

Company	Round	Date	Alongside
TT-Therapeutics	Series B+ · $133M	Nov 5, 2026	Digitalis Ventures, Cambridge Innovation Capital, Johnson & Johnson Innovation +6
EEka Robotics	Series A · $150M · lead	Oct 20, 2026	Andreessen Horowitz (lead)
AAblePay Health	Series A · $20M · lead	Oct 8, 2026	A1 Health Ventures, .406 Ventures
AArboretum	Series A · $30M · lead	Oct 6, 2026	.406 Ventures, Amgen, Hims +1
AAmber Therapeutics	Series A · $100M	Jul 24, 2026	Lightstone Ventures, NEA (lead), 8VC +2
CCyclops	Series A · $20M	Jul 1, 2026	Coinbase, Circle, Castle Island Ventures +2
33F Labs	Seed	Apr 23, 2026	Felix Lutsch, GSR Markets, Komorebi Collective +7
33F	Seed · $4M	Apr 1, 2026	GSR Markets, Komorebi Collective, Maven 11 Capital +5

How F-Prime Capital invests

Stage	Deals	Capital in rounds
Series B+	36 49%	$2.7B
Series A	27 36%	$1.25B
Seed	8 11%	$73.5M
round	3 4%	$58M

Year	Deals	Capital in rounds
2016	1 1%	$4.5M
2017	3 4%	$100.4M
2018	1 1%	$34M
2019	3 4%	$55M
2020	5 7%	$554M
2021	10 14%	$422.2M
2022	8 11%	$264.5M
2023	7 9%	$464M
2024	10 14%	$661.8M
2025	13 18%	$627M
2026	13 18%	$893.95M

F-Prime Capital portfolio companies

TT-Therapeutics$133MSeries B+ · Nov 2026
EEka Robotics$150MSeries A · Oct 2026
AAblePay Health$20MSeries A · Oct 2026
AArboretum$30MSeries A · Oct 2026
AAmber Therapeutics$100MSeries A · Jul 2026
CCyclops$20MSeries A · Jul 2026
33F LabsSeed · Apr 2026
33F$4MSeed · Apr 2026
IImmutrin$86.45MSeries A · Mar 2026
RR1 Therapeutics$77.5MSeries A · Mar 2026
SSTS Digital$30Mround · Feb 2026
TTenpoint Therapeutics$235MSeries B+ · Jan 2026
LLimitless$10MSeed · Oct 2025
KKanastra$30MSeries B+ · Oct 2025
AAmplifyMD$20MSeries B+ · Sep 2025
DDebut$20Mround · Aug 2025
AARTBIO$132MSeries B+ · Jul 2025
AAshby$50MSeries B+ · Jul 2025
SSpinwheel$30MSeries A · Jul 2025
CCanary Technologies$80MSeries B+ · Jun 2025
AAxle Health$10MSeries A · May 2025
TToku$48MSeries A · Apr 2025
11Money$20MSeed · Jan 2025
RRhyGaze$86MSeries A · Jan 2025
NNotabene$14.5MSeries B+ · Nov 2024
AAvenCell$112MSeries B+ · Oct 2024
QQuantum Circuits$60MSeries B+ · Aug 2024
OOdaseva$54MSeries B+ · Jun 2024
EEngrail Therapeutics$157MSeries B+ · Mar 2024
CComanche Biopharma$75MSeries B+ · Jan 2024
DDevoted Health$175MSeries B+ · Dec 2023
KK36 Therapeutics$70MSeries B+ · Jun 2023
11Uphealth$40MSeries B+ · Apr 2023
PPulmocide$52MSeries B+ · Dec 2022
PProximie$80MSeries B+ · Jun 2022
DDoceree$11MSeries A · Apr 2022
LLogixboard$32MSeries B+ · Jan 2022
MMoEngage$30MSeries B+ · Dec 2021
NNotable$100MSeries B+ · Nov 2021
CCentivo$51MSeries B+ · Sep 2021
AArgyle$20MSeries A · Oct 2020
AAvantStay$20MSeries A · Sep 2019
VVestwell$30MSeries B+ · Apr 2019
WWarmlybacker
PParadigm Healthbacker
FFunnelbacker
SStridebacker
LLumabacker
VVenicebacker
AArnatar Therapeuticsbacker
TTenviebacker
OOwkinbacker
RRecurlybacker
DDinaribacker
SSnapdocsbacker
EEnsomabacker
CChaos Labsbacker
LLemon Cashbacker
LLaurus Biobacker
CCarrot Fertilitybacker
XXaira Therapeuticsbacker

Company	Round with F-Prime Capital	Total raised	Latest raise
TT-Therapeutics Health and bio	Nov 5, 2026 Series B+ · $133M	$283M	Nov 5, 2026 Series B+
EEka Robotics Robotics and hardware	Oct 20, 2026 Series A · $150M · lead	$150M	Oct 20, 2026 Series A
AAblePay Health Fintech	Oct 8, 2026 Series A · $20M · lead	$20M	Oct 8, 2026 Series A
AArboretum Health and bio	Oct 6, 2026 Series A · $30M · lead	$30M	Oct 6, 2026 Series A
AAmber Therapeutics Health and bio	Jul 24, 2026 Series A · $100M	$200M	Jul 24, 2026 Series A
CCyclops Stablecoins	Jul 1, 2026 Series A · $20M	$28M	Jul 1, 2026 Series A
33F Labs	Apr 23, 2026 Seed	$4M	Apr 23, 2026 Seed
33F Stablecoins	Apr 1, 2026 Seed · $4M	$4M	Apr 1, 2026 Seed
IImmutrin Health and bio	Mar 26, 2026 Series A · $86.45M	$86.45M	Mar 26, 2026 Series A
RR1 Therapeutics Health and bio	Mar 17, 2026 Series A · $77.5M · lead	$158M	Sep 30, 2026 Series A
SSTS Digital	Feb 1, 2026 round · $30M	$30M	Feb 1, 2026 round
TTenpoint Therapeutics Health and bio	Jan 29, 2026 Series B+ · $235M	$235M	Jun 12, 2026 Series A
LLimitless Prediction markets	Oct 20, 2025 Seed · $10M	$13M	Oct 20, 2025 Seed
KKanastra Fintech	Oct 1, 2025 Series B+ · $30M · lead	$64M	Oct 1, 2025 Series B+
AAmplifyMD Health and bio	Sep 24, 2025 Series B+ · $20M	$43M	Sep 24, 2025 Series B+
DDebut Health and bio	Aug 26, 2025 round · $20M · lead	$20M	Aug 26, 2025 round
AARTBIO Health and bio	Jul 29, 2025 Series B+ · $132M	$245M	Jul 29, 2025 Series B+
AAshby HR and recruiting	Jul 22, 2025 Series B+ · $50M	$101.5M	Jul 22, 2025 Series B+
SSpinwheel Fintech	Jul 1, 2025 Series A · $30M · lead	$41M	Jul 13, 2026 Series A
CCanary Technologies Fintech	Jun 12, 2025 Series B+ · $80M	$255M	Jul 6, 2026 Series B+
AAxle Health Health and bio	May 22, 2025 Series A · $10M · lead	$14.2M	May 22, 2025 Series A
TToku Fintech	Apr 17, 2025 Series A · $48M	$64.3M	Apr 17, 2025 Series A
11Money Stablecoins	Jan 16, 2025 Seed · $20M · lead	$20M	Jan 16, 2025 Seed
RRhyGaze Health and bio	Jan 10, 2025 Series A · $86M	$97M	Jan 10, 2025 Series A
NNotabene Stablecoins	Nov 12, 2024 Series B+ · $14.5M	$24.82M	Nov 12, 2024 Series B+
AAvenCell Health and bio	Oct 22, 2024 Series B+ · $112M	$112M	Oct 22, 2024 Series B+
QQuantum Circuits Robotics and hardware	Aug 16, 2024 Series B+ · $60M · lead	$78M	Aug 16, 2024 Series B+
OOdaseva Legal and compliance	Jun 27, 2024 Series B+ · $54M	$90.7M	Jun 27, 2024 Series B+
EEngrail Therapeutics Health and bio	Mar 19, 2024 Series B+ · $157M · lead	$221M	Mar 19, 2024 Series B+
CComanche Biopharma Health and bio	Jan 1, 2024 Series B+ · $75M	$75M	Feb 26, 2025 Series B+
DDevoted Health Insurance	Dec 29, 2023 Series B+ · $175M	$2.27B	Mar 26, 2026 Series B+
KK36 Therapeutics Health and bio	Jun 28, 2023 Series B+ · $70M	$100M	Jun 28, 2023 Series B+
11Uphealth Health and bio	Apr 1, 2023 Series B+ · $40M	$75M	Feb 23, 2026 Series B+
PPulmocide Health and bio	Dec 6, 2022 Series B+ · $52M	$174.4M	Dec 6, 2022 Series B+
PProximie Health and bio	Jun 1, 2022 Series B+ · $80M	$118M	Sep 18, 2024 Series B+
DDoceree Sales and marketing	Apr 1, 2022 Series A · $11M · lead	$25.6M	Aug 4, 2026 Series B+
LLogixboard Sales and marketing	Jan 26, 2022 Series B+ · $32M	$50M	Jan 26, 2022 Series B+
MMoEngage AI coding and devtools	Dec 1, 2021 Series B+ · $30M	$238.25M	Dec 21, 2025 Series B+
NNotable AI agents	Nov 4, 2021 Series B+ · $100M	$109M	Sep 30, 2025 Series A
CCentivo Insurance	Sep 22, 2021 Series B+ · $51M	$194M	Sep 24, 2024 round
AArgyle Lending and credit	Oct 1, 2020 Series A · $20M	$108M	Mar 7, 2024 Series B+
AAvantStay Health and bio	Sep 1, 2019 Series A · $20M	$185M	Jul 13, 2026 Series B+
VVestwell Lending and credit	Apr 2, 2019 Series B+ · $30M	$622.5M	Feb 18, 2026 Series B+
WWarmly Sales and marketing	backer · source	$6M	Feb 4, 2025 Series A
PParadigm Health Health and bio	backer · source	$78M	Dec 4, 2025 Series B+
FFunnel Sales and marketing	backer · source	$32M	Nov 1, 2023 Series B+
SStride Fintech	backer · source	undisclosed	—
LLuma In-person and live experiences	backer · source	undisclosed	—
VVenice	backer	undisclosed	—
AArnatar Therapeutics Health and bio	backer	$102M	Mar 14, 2026 Series A
TTenvie Health and bio	backer	undisclosed	Jan 8, 2025 round
OOwkin Health and bio	backer	undisclosed	—
RRecurly Fintech	backer	undisclosed	—
DDinari Stablecoins	backer	undisclosed	—
SSnapdocs Fintech	backer	undisclosed	Sep 20, 2025 Series B+
EEnsoma Health and bio	backer	$50M	May 16, 2023 Series B+
CChaos Labs	backer	$75M	Aug 15, 2024 Series A
LLemon Cash Fintech	backer	$36.3M	Oct 9, 2025 Series B+
LLaurus Bio Health and bio	backer	$14.4M	Feb 11, 2025 Series B+
CCarrot Fertility Health and bio	backer	undisclosed	May 23, 2025 Seed
XXaira Therapeutics Health and bio	backer	undisclosed	Mar 23, 2026 round

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 74 rounds on Recent Funding that name F-Prime Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists F-Prime Capital, which is a subset of its real portfolio. API: /api/v1/investors/f-prime-capital (get a free API key). More: the most active VC firms and new venture capital funds.